Michaela Retzer-Lidl et al. [24] found that inhibition of CDK4 impairs the proliferation of pancreatic cancer cells and sensitizes them to TRAIL-induced apoptosis. The gene discussed is CDK4; the disease is familial pancreatic carcinoma.